MedPath

Effect of Exercise and Salvia officinalis on Postmenopausal Wome

Phase 3
Conditions
Condition 1: Postmenopausal Women. Condition 2: Insulin resistance.
Postmenopausal
Impaired glucose tolerance (oral)
Z79.890
R73.02
Registration Number
IRCT20140415017288N9
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
32
Inclusion Criteria

being menopausal
Age range 50-65 years
Inactive lifestyle (exercise less than 1 hour per week)
Not taking medicine in the last 6 months.
Being willing to participate in the study.

Exclusion Criteria

Supplement use.
Diagnosis of other diseases during the implementation of the protocol.
Not taking Salvia officinalis.
Use of estrogen and other androgens and steroids that affect estrogen receptors.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tumor Necrosis Factor Alpha. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).;Interleukin-10. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).;Interleukin-12. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).;Fasting blood glucose. Timepoint: Before and after the protocol. Method of measurement: Biochemical methods.;Fasting blood insulin. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).;Insulin resistance index (HOMA-IR). Timepoint: Before and after the protocol. Method of measurement: formulas.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath